With tightening regulations and rising costs, the pharmaceutical industry is being presented with a consistent challenge in the marketplace: Do more with less. As a result, pharma companies are reducing their internal capacities in manufacturing and R&D and are, instead, increasing their outsourcing. More than ever, these companies are relying on external service providers to fulfill their manufacturing needs and improve their productivity. In 2016, a study from Industry Standard Research Reports revealed that life sciences companies now outsource two-thirds of their manufacturing activities to CMOs. That figure is even higher for small and mid-sized companies: up to 80% in 2015.